Our Story

BioHermes is a high-tech IVD enterprise, founded by a group a scientists trained in the U.S. The history can trace back to year 2006, when we started to produce obstetric products such like fFN and IGFBP-1 for the pregnant women. The significant moment came in 2013 when we acquired the innovative HbA1c testing technology from U.S. based Scripps Laboratories. Such technology eventually enabled us to further develop our current major products, including A1C EZ 2.0, GluCoA1c, A1cChek Pro and A1cChek Express.

BioHermes changes the way people perform an HbA1c test, making it possible for users to monitor HbA1c more frequently at almost any site with much reduced cost. Today, our products are widely sold in more than 50 countries, and are extensively used in clinics, laboratories, hospitals across the globe.

We endeavor to provide the most convenient, accurate, and affordable tests to people for the prevention of diabetes and its complications and continuously forge ahead with one "Vision" in our mind.

Our Quality System/Certificates/Patents

☑ ISO 13485 Certificated Quality System

☑ 100% CE marked & registered products

☑ EZ 2.0 FDA 510k cleared

☑ A1cCheck Pro FDA CLIA Waiver submitted

☑ CFDA & KFDA inspected facility

☑ Property rights and patients over 17 countries

Our People

Our team combines experience in biochemistry, engineering, manufacture and marketing
Meet the people leading BioHermes’s vision

Eric Xu

Chairman


PHD, Texas A&M University
Postdoc, UC Berkeley
Co-founder of Baidu

Yan Liu

General Manager

MBA, SUFE

Former BU Head of Heart,
Brain & Kidney Therapeutic
Field, Bayer China

Joseph E.Ruggiero

CPO

Former Director of A1CNow
department, Bayer

40-year experience of R&D
in medical devices

Kimi Luo

Department Manager of Overseas
Sales and Marketing


Bachelor of Pharmaceutical
Engineering in Biology

10-year int'l experience of
IVD products management